GUDC inhibits cytochrome c release from human cholangiocyte mitochondria

Journal of Surgical Research

Volumn 83, Issue 2, 1999, Pages 100-105

  Que, Florencia G ^a   Phan, Vy A ^a   Phan, Van H ^a   Larusso, Nicholas F ^a   Gores, Gregory J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Beauvericin; Caspase; Caspase 3; Cholangiocytes; Cytochrome c; Fluorogenic caspase protease substrates

Indexed keywords

BEAUVERICIN; BILE ACID; CASPASE 3; CYTOCHROME C; GLYCODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

APOPTOSIS; ARTICLE; BILE DUCT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033562147     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5574     Document Type: Article

References (28)

1. Batts K. P., Jorgensen R. A., Dickson R., Lindor K. D. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 91:1996;2314.
2. Stiehl A. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis. Scand. J. Gastroenterol. 204:1994;59.
3. Kuroki T., Seki S., Kawakita N., Nakatani K., Hisa T. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virch. Arch. 429:1996;119.
4. Lindor K. D., Therneau T. M., Jorgensen R. A., Malinchoc M., Dickson E. R. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 110:1996;1515.
5. Hayashi H., Higchi T., Ichimiya H., Hishida N., Sakamoto N. Asymptotic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology. 99:1990;533.
6. +. Gastroenterology. 113:1996;1734.
7. Lazaridis K. N., Pham L., Broman B., deGroen P. C., LaRusso N. F. Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes. Am. J. Physiol. 272:1996;G1168.
8. Que F. G., Gores G. J., LaRusso N. F. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am. J. Physiol. 272:1997;G106.
9. Mariani S. M., Matiba B., Armandola E. A., Krammer P. H. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol. 137:1997;221.
10. Bossy-Wetzel E., Newmeyer D. D., Green D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37.
11. Zou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. Elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405.
12. Botla R., Spivey J. R., Aguilar H., Bronk S. F., Gores G. J. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by Glycochenodeoxycholate: A mechanism of UDCA cytoprotection. J. Pharmacol. Exp. Ther. 272:1995;930.
13. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis [see Comments]. Science. 275:1997;1132.
14. Yang, J. Liu, X. Bhalla, K. et al., Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked, 1997.
15. Grubman S. A., Perrone R. D., Lee D. W. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am. J. Physiol. 266:1994;G1060.
16. Spivey J. R., Bronk S. F., Gores G. J. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. J. Clin. Invest. 92:1993;17.
17. Bernuau D., Feldmann G., Degott C., Gisselbrecht C. Ultrastructural lesions of bile ducts in primary biliary cirrhosis. Hum. Pathol. 12:1981;782.
18. Krams S. M., Egawa H., Quinn M. B., Villanueva J. C., Garcia-Kennedy R., Martinez O. M. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation. 59:1995;621.
19. Martinez O. M., Billanueva J. C., Gershwin M. E., Krams S. M. Cytokines patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology. 21:1995;113.
20. Nawaz S., Fennell R. H. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology. 25:1994;137.
21. Roberts J. M., Searle J. W., Cooksley W. G. E. Histological patterns of prolonged hepatitis C infection. Gastroenterol. Jpn. 28:1993;37.
22. Searle J., Harmon B. V., Bishop C. J., Kerr J. F. R. The significance of cell death by apoptosis in hepatobiliary disease. J. Gastroenterol. Hepatol. 2:1987;77.
23. Fernandes-Alnemri T., Litwack G., Alnemri E. S. CPP32, a novel human apoptotic protein with homology tocaenorhabditis elegans. J. Biol. Chem. 269:1994;30761.
24. Hasegawa J., Kamada S., Kamiike W. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res. 56:1996;1713.
25. Kharbanda S., Pandey P., Scholfield L. Role for Bcl-xl as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;6939.
26. Marchetti P., Castedo M., Susin S. A. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1996;1155.
27. 1. Cell. 91:1997;627.
28. Saas P., Walker P. R., Hahne M. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? J. Clin. Invest. 99:1997;1173.